BHB
Bar Harbor Bankshares
BHB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over BHB overall, supported by stronger modeled upside and stronger valuation.
BHB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BHB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BHB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $31.73 | -23% |
| Fair | 11x | $38.75 | -6.4% |
| Forward | 11x | $41.39 | — |
| Current | 12x | $41.39 | — |
| Expensive | 14x | $45.87 | +11% |
Historical ranges are pointers, not guarantees.
BHB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect BHB's earnings, revenue and profitability to hold roughly steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BHB on the outlook, with more favorable earnings and revenue expectations.
BHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.80 | +12% |
| Q3 2026 | $3.39 | +47% |
| Q2 2026 | $2.97 | +16% |
| Q1 2026 | $2.46 | -13% |
| Q4 2025 | $2.31 | -19% |
| Q3 2025 | $2.31 | -17% |
| Q2 2025 | $2.57 | -5.2% |
| Q1 2025 | $2.84 | +3.3% |
| Q4 2024 | $2.84 | -3.7% |
BHB earned $3.39 per share over the past year, up 47% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BHB on earnings, with more consistent year-over-year improvement.
BHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $51.6M | +8.5% |
| Q2 2026 | $49.7M | +44% |
| Q1 2026 | $47.3M | +25% |
| Q4 2025 | $48.9M | +27% |
| Q3 2025 | $47.5M | +23% |
| Q2 2025 | $34.5M | -7.6% |
| Q1 2025 | $37.9M | +3.5% |
| Q4 2024 | $38.5M | +2.2% |
BHB's revenue has grown year over year for five quarters in a row: $52M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +16 points |
| Q2 2026 | 39% | +17 points |
| Q1 2026 | 36% | +2.8 points |
| Q4 2025 | 30% | -5.1 points |
| Q3 2025 | 23% | -12 points |
| Q2 2025 | 22% | -13 points |
| Q1 2025 | 33% | -1.1 points |
| Q4 2024 | 35% | +1.8 points |
BHB has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.3M | +12% |
| Q2 2026 | $21.8M | +564% |
| Q1 2026 | $3M | -61% |
| Q4 2025 | $17M | +37% |
| Q3 2025 | $15.4M | -31% |
| Q2 2025 | $3.3M | +44% |
| Q1 2025 | $7.8M | -0.9% |
| Q4 2024 | $12.4M | -6.6% |
BHB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +19.5K shares |
| 1 year | +3.3% | +544K shares |
| 3 years | +11% | +1.6M shares |
| 5 years | +12% | +1.8M shares |
| Available history | +7.9% | +1.2M shares |
BHB has 17M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $718,000 |
| Q3 2020 | $6M |
| Q2 2020 | $7.3M |
| Q1 2020 | $130,000 |
| Q4 2019 | $107,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BHB on shareholder dilution, with a more favorable share count trend.
BHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 3.8x | Elevated |
BHB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.3 | Neutral |
| Stochastic | 68.3 | Neutral |
BHB's weekly RSI is 64 (neutral) and its Stochastic is 68 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BHB PE vs Financial Services Sector
| Metric | BHB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.2% below |
| PE % | 64 | 63 | 1 pt above |
BHB has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.7 | 4.2% above |
| 20 week MA | $39.5 | 4.8% above |
| 50 week MA | $36.1 | 15% above |
| 100 week MA | $33.2 | 25% above |
| 200 week MA | $30.3 | 36% above |
BHB has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.4 | $22.1 | -13% |
| 2021 | $22.1 | $29.2 | +32% |
| 2022 | $29.2 | $31.1 | +6.2% |
| 2023 | $31.1 | $29.4 | -5.5% |
| 2024 | $29.4 | $30.3 | +3% |
| 2025 | $30.3 | $31.9 | +5.4% |
| 2026 YTD | $31.9 | $41.4 | +30% |
BHB has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.